Stonepine Capital Management »

Si-bone shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Si-bone (SIBN) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Si-bone

Tip: Access up to 7 years of quarterly data

All positions including Si-bone held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Si-bone by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 115k 12.63

More positions owned by Stonepine Capital Management

Spdr Series Trust State Street Spd Put Option (XBI)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Evolus (EOLS)
Camp4 Therapeutics Corp (CAMP)
Nektar Therapeutics Com New (NKTR)
Terns Pharmaceuticals Call Option (TERN)
Zevra Therapeutics Com New (ZVRA)
Abeona Therapeutics Com New (ABEO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Establishment Labs Holdings Ord Call Option (ESTA)
Kazia Therapeutics Sponsored Ads (KZIA)
An2 Therapeutics (ANTX)
Alexandria Real Estate Equities Call Option (ARE)

View all positions for Stonepine Capital Management

Top funds holding Si-bone

First Light Asset Management
BlackRock
American Century Companies
Brown Advisory Holdings Incorporated
Cadian Capital Management
Vanguard Capital Management
Granahan Investment Management
Impax Asset Management Group
Nuveen
Silvercrest Asset Management Group
State Street Corporation
Paradigm Capital Management
Gilder, Gagnon, Howe & Co
Geode Capital Management
Champlain Investment Partners

View all funds holding Si-bone